Nimit Ghatalia Increases Aarey Drugs Stake to 5.18%

Summary of Key Information:

Acquirer / Seller / Promoter: Nimit Rajesh Ghatalia

Target Company: Aarey Drugs & Pharmaceuticals Ltd

Nature of Transaction / Event: Shareholding acquisition through warrant conversion

Date of Transaction: 30/09/2026

Number of Shares Affected: 150,000

% of Total Shareholding / Voting Capital Affected: Acquisition increased holding by 0.47 percentage points to 5.18%

Mode of Transaction / Action: Allotment pursuant to conversion of warrants

Consideration (if disclosed): Not disclosed

Shareholding / Promoter Snapshot (Before & After):

Before Transaction / Event:

• Shares Held: 1,500,000
• % of Total Capital: 4.88%

After Transaction / Event:

• Shares Held: 1,650,000
• % of Total Capital: 5.18%

Pledged / Encumbered Shares: Not applicable, as no encumbrances were disclosed.

Unencumbered Shares: All shares are unencumbered, as per the disclosure.

Other Noteworthy Information:

• Nimit Rajesh Ghatalia belongs to the Promoter/Promoter Group of the company.
• The disclosure is made under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, Regulation 29(1).
• Equity share capital before acquisition: 30,724,303 shares of Rs. 10 each.
• Equity share capital after acquisition: 31,874,303 shares of Rs. 10 each.
• Total diluted share capital after acquisition: 33,354,303 shares.
• PAN of the acquirer: BBCPG4901J.

Analyst Notes:

This summary presents factual information from the regulatory filing without speculation. All figures and percentages are as reported in the disclosure.